Biolase (BIOL) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts BIOL Hot Sheet
Join SI Premium – FREE
Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $10.8 million versus the consensus estimate of $13.65 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Tesla to launch Cybercab in Austin this month - report
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
